CRISIL Ltd. Coverage Initiation Report
CRISIL Ltd. Coverage Initiation Report
Initiating Coverage
Crisil Ltd.
1
Crisil Ltd.
Industry LTP Recommendation Base Case Fair Value Bull Case Fair Value Time Horizon
Credit Rating Rs 3387 Buy in Rs 3380-3420 band & add more on dips to Rs 3000-3040 band Rs 3703 Rs 3942 2 quarters
Share holding Pattern % (Dec, 2021) Diversified revenue mix, levers for margin expansion, and solid return ratios have seen CRISIL's valuation multiplies stay at a premium and
Promoters 66.9
to its peers. Preference for quality has seen investors/lenders prefer CRISIL, propelling it to be the best play in an otherwise crowded
Institutions 13.2
rating space.
Non Institutions 19.9
Total 100.0
Valuation & Recommendation:
CRISIL’s superior rating standards, diversified and innovative product offerings and strong analytics skills has enabled it to emerge as the
strongest credit rating agency (CRA) across business cycles. Improving corporate capex and additional levers with ESG ratings, has
improved the outlook for the domestic ratings business. We expect CRISIL’s revenue/EBITDA/PAT to grow at 13/15/18% CAGR over CY21-
CY23E, led by improving macros, market share gains, cost rationalization, and synergies from acquisitions. It is likely to trade at a premium
to its peers given its strong parentage, return ratios and diversified revenue mix. We believe investors can buy the stock in Rs 3380-3420
* Refer at the end for explanation on Risk Ratings
band and add on dips to Rs 3000-3040 band (38x CY23E EPS) for a base case fair value of Rs 3703 (46.5x CY23E EPS) and bull case fair
Fundamental Research Analyst value of Rs 3942 (49.5x CY23E EPS) over the next 2 quarters.
Atul Karwa
[Link]@[Link]
2
Crisil Ltd.
Financial Summary
Particulars (Rs cr) Q4CY21 Q4CY20 YoY (%) Q3CY21 QoQ (%) CY20 CY21 CY22E CY23E
Operating Income 706 597 18.2 571 23.7 1,982 2,301 2,608 2,897
EBITDA 193 154 24.9 147 31.4 511 606 694 782
APAT 134 110 22.1 113 19.0 355 431 504 580
Diluted EPS (Rs) 18.4 15.2 21.6 15.5 18.9 48.9 59.2 69.1 79.6
RoE (%) 28.6 29.8 30.5 32.0
P/E (x) 69.3 57.2 49.0 42.5
EV/EBITDA (x) 47.2 39.5 34.3 30.0
(Source: Company, HDFC sec)
The Board of Directors have recommended a final dividend of Rs 15 per share and a special dividend of Rs 7 per share taking the total
dividend for the year to Rs 46 per share.
Activity in the lending markets improved in line with economic recovery. Companies increasingly sought to refinance debt and strengthened
their liquidity positions. Ratings business segment saw increased penetration in the mid-corporate segment and traction for stressed asset
offerings. In Research, the Global Research & Risk Solutions (GR&RS) business saw client wins and continued to grow through the December
quarter. Domestic research business witnessed growth following the pick-up in economic activity. The Advisory segment bagged large wins
from multilaterals and expanded its overseas clients’ footprint. The Global Analytical Centre (GAC) business stepped up support for
surveillance, new issuances and transformation projects to S&P.
Key Triggers
Improving macros, low interest rates to drive higher credit demand
Moody’s expects India’s economy to continue to recover in the next 12-18 months, with GDP growing 9.1% in CY22 and projected that the
Indian economy will grow at 5.4% during the CY23. The agency noted that the speed of the recovery from the first lockdown-led contraction
3
Crisil Ltd.
in Q22020, and subsequently in Q22021 during the Delta wave was stronger than expected, and the economy is estimated to have
surpassed the pre-Covid level of GDP by more than 5% in the last quarter of 2021. With demand picking up across the economy, activity in
the lending markets is improving and there are increasing signs of companies enhancing their bank lines and seeking refinancing.
Credit growth, which had been languishing through 2021 due to Covid-19 and also deleveraging of balance sheets by large corporates, has
been recovering as indicated by the RBI data. Increasing credit would drive higher demand for ratings, benefitting rating agencies like
CRISIL. Amid a spike in credit offtake by the industry, non-food bank credit saw 8.3% YoY growth in January, much above the 5.9% level a
year ago, as per latest RBI data. The RBI said credit growth to industry rose 6.4% in January from 0.7% in the same month last year.
India Ratings & Research expects credit growth to clock 10% in 2022-23 for the first time since 2013-14 when it had hit 14%. It has however,
reduced its estimate for the current fiscal ending March 2022 to 8.4% from 8.9%.
4
Crisil Ltd.
Limited Purpose Clearing Corporation for repo in corporate bonds. As per trends in the corporate bond market, around 97-98% of the
corporate bonds are issued through the private placement route and around 90% of the issuances are of 'AA' and above ratings. Trading in
the secondary market lacks depth and is largely dominated by mutual funds.
SEBI has taken certain initiatives and some more are in the pipeline. The measures taken by the regulator include limiting the number of
ISINs (International Securities Identification Numbers) in a year, mandating certain minimum borrowing through bonds for large borrowers
and introducing RFQ (Request for Quote) platform to improve pre and post-trade transparency.
The reforms will help in bringing liquidity and stability to the corporate debt market, address risk aversion during times of stress specially for
securities rated below AAA, help in building confidence of market participants in the secondary market and create liquidity options for
investors at large.
With higher number of participants and more liquidity, issues in the bond market are likely to increase leading to higher rating business for
rating agencies.
CRISIL operates on asset-light model and generates huge cash. Effective utilisation of cash is vital to ensure earning sufficient RoEs on this
cash. CRISIL has at regular intervals resorted to acquisitions in the research business which has resulted in diversification in revenues while
also being RoE accretive.
5
Crisil Ltd.
Regulatory scrutiny
Credit rating agencies (CRAs) have come under regulatory scrutiny in the wake of loan defaults by leading corporates. To enhance CRAs’
rating process and quality of disclosures, SEBI keeps prescribing higher disclosure of data by CRAs. This apart CRAs come under scrutiny of
regulators and are also fined for lapses that may not be fully attributable to them.
Increasing competition
There are three major established players in the Indian credit rating market and over the last few years many new players have entered the
market, thereby increasing competition. Many clients look for the best deal they can get reducing the bargaining power of credit rating
agencies.
6
Crisil Ltd.
Retention of employees, a challenge
Employees are the core asset for a credit rating agency and hence retaining them is crucial. While CRISIL remains the best paymaster, the
risk of employee movement can expose it to risks of attrition, retraining and reskilling.
Company Background:
CRISIL is a global analytical company providing ratings, research, and risk and policy advisory services. It is amongst India's leading ratings
agency and the foremost provider of high-end research to the world's largest banks and leading corporations. CRISIL is majority owned by
S&P Global Inc., a leading provider of transparent and independent ratings, benchmarks, analytics and data to the capital and commodity
markets worldwide.
With a strong track record of growth, culture of innovation and global footprint it has delivered independent opinions, actionable insights
and efficient solutions to over 100,000 customers. Its businesses operate from India, Argentina, Australia, China, Hong Kong, Poland,
Singapore, Switzerland, the United Arab Emirates (UAE), The United Kingdom (UK) and the United States of America (USA).
Businesses
Crisil Ratings pioneered credit rating in India in 1987, and has emerged as a leader with independent, analytical rigour and innovation in
ratings. Its capabilities span the entire range of debt instruments. Through its Global Analytical Centre (GAC), it provides analytical,
research and data services to S&P Global Inc. GAC operates as a centralised research and analytics hub for S&P Global Ratings Services
(SPGRS) teams spread across the US, EMEA and APAC regions.
CRISIL Coalition provides objective research and high-end analytics to support strategic and tactical decision-making across four areas:
competitor analytics, financial resources analytics, client analytics, and country analytics.
7
Crisil Ltd.
Greenwich Associates: Acquired in 2020 Feb’2020 for a consideration of US$40mn, it is a leading global provider of data, analytics and
insights to the financial services industry. It specialises in providing unique high-value data and actionable recommendations to help our
clients improve their business results.
CRISIL Infrastructure Advisory provides a comprehensive range of advisory services in urban, energy and natural resources, transport and
logistics, and infrastructure financing across India and other emerging countries to governments, multilateral agencies, investors, large
public and private sector firms.
Revenue breakup
8
Crisil Ltd.
Segmental Performance
(Rs cr) Q4CY21 Q4CY20 YoY (%) Q3CY21 QoQ (%) CY21 CY20 YoY (%)
Revenue
Rating Services 165 151 9.5 154 7.4 604 565 6.9
Advsiory Serices 47 40 17.6 36 31.3 153 134 14.0
Research & Information Services 494 407 21.5 382 29.5 1544 1283 20.3
Revenue Share (%)
Rating Services 23.4 25.2 -186 bps 26.9 -354 bps 26.3 28.5 -225 bps
Advsiory Serices 6.6 6.7 -3 bps 6.2 39 bps 6.6 6.8 -12 bps
Research & Information Services 70.0 68.1 189 bps 66.9 315 bps 67.1 64.7 237 bps
EBIT
Rating Services 66 58 13.8 64 2.4 253 226.7 11.5
Advsiory Serices 9 6 37.5 1 990.1 17 10.1 64.8
Research & Information Services 108 71 51.2 84 28.7 324 209.0 55.1
EBIT Margin (%)
Rating Services 40.0 38.5 150 bps 41.9 -194 bps 41.8 40.1 171 bps
Advsiory Serices 18.9 16.1 274 bps 2.3 1661 bps 10.9 7.5 335 bps
Research & Information Services 21.7 17.5 427 bps 21.9 -13 bps 21.0 16.3 470 bps
Peer Comparision
CMP Mcap EPS OPM PATM RoE D/E P/E P/B
(FY21)
(Rs) (Rs cr) (Rs) (%) (%) (%) (x) (x) (x)
CRISIL (CY21) 3387 24713 59.1 26.3 18.7 27.3 0.0 57.2 15.6
ICRA 4102 3959 84.6 26.9 27.1 10.8 0.0 48.5 5.2
CARE Ratings 508 1505 30.2 38.6 36.0 15.2 0.0 16.8 2.6
9
Crisil Ltd.
Financials
Income Statement Balance Sheet
(Rs cr) CY19 CY20 CY21 CY22E CY23E As at March (Rs cr) CY19 CY20 CY21 CY22E CY23E
Net Revenues 1732 1982 2301 2608 2897 SOURCE OF FUNDS
Growth (%) -1.0 14.4 16.1 13.4 11.1 Share Capital 7 7 7 7 7
Operating Expenses 1276 1471 1695 1914 2114 Reserves & Surplus 1165 1305 1571 1722 1896
EBITDA 456 511 606 694 782 Shareholders' Funds 1172 1312 1578 1730 1904
Growth (%) -3.3 12.0 18.6 14.5 12.7 Minority Interest 0 0 0 0 0
EBITDA Margin (%) 26.3 25.8 26.3 26.6 27.0 Total Debt 3 0 0 0 0
Depreciation 37 121 106 103 100 Net Deferred Taxes -43 -64 -59 -59 -59
Other Income 73 83 82 91 104 Total Sources of Funds 1132 1248 1519 1670 1844
EBIT 492 473 582 682 786 APPLICATION OF FUNDS
Interest expenses 0 14 9 9 10 Net Block & Goodwill 349 763 661 598 539
PBT 492 458 618 673 776 CWIP 12 14 5 3 1
Tax 148 104 153 170 196 Investments 453 476 645 795 970
PAT 344 355 466 504 580 Other Non-Curr. Assets 120 112 149 182 208
Share of Asso./Minority Int. 0 0 0 0 0 Total Non Current Assets 933 1364 1460 1577 1718
Adj. PAT 344 355 431 504 580 Debtors 199 307 399 414 436
Growth (%) -5.3 3.1 21.6 16.8 15.2 Cash & Equivalents 346 279 294 331 449
EPS 47.6 48.9 59.2 69.1 79.6 Other Current Assets 168 193 291 329 361
Total Current Assets 713 779 984 1074 1247
Creditors 75 105 134 135 157
Other Current Liab & Provisions 439 789 792 846 963
Total Current Liabilities 514 895 925 981 1120
Net Current Assets 199 -116 59 93 126
Total Application of Funds 1132 1248 1519 1670 1844
10
Crisil Ltd.
Cash Flow Statement Key Ratios
(Rs cr) CY19 CY20 CY21 CY22E CY23E CY19 CY20 CY21 CY22E CY23E
PBT 492 458 618 673 776 Profitability Ratios (%)
Non-operating & EO items -14 -21 -70 -31 -26 EBITDA Margin 26.3 25.8 26.3 26.6 27.0
Interest Expenses -7 10 -1 9 10 EBIT Margin 28.4 23.9 25.3 26.2 27.1
Depreciation 37 121 106 103 100 APAT Margin 19.9 17.9 18.7 19.3 20.0
Working Capital Change 84 57 -54 1 85 RoE 29.8 28.6 29.8 30.5 32.0
Tax Paid -146 -125 -197 -170 -196 RoCE 42.5 38.0 40.2 41.3 43.3
OPERATING CASH FLOW ( a ) 446 500 403 585 750 Solvency Ratio (x)
Capex -28 -34 27 -37 -40 Net Debt/EBITDA -0.8 -0.5 -0.5 -0.5 -0.6
Free Cash Flow 418 466 430 548 710 Net D/E -0.3 -0.2 -0.2 -0.2 -0.2
Investments -56 -44 -130 -150 -175 PER SHARE DATA (Rs)
Non-operating income 6 -222 15 0 0 EPS 47.6 48.9 59.2 69.1 79.6
INVESTING CASH FLOW ( b ) -77 -300 -88 -187 -215 CEPS 52.7 65.5 73.7 83.2 93.4
Debt Issuance / (Repaid) 0 0 0 0 0 BV 162.1 180.7 216.5 237.2 261.1
Interest Expenses 0 0 0 -9 -10 Dividend 32.0 33.0 46.0 48.4 55.7
FCFE 368 200 315 389 525 Turnover Ratios (days)
Share Capital Issuance 23 35 44 0 0 Debtor days 51.0 46.7 56.0 56.9 53.6
Dividend -252 -232 -276 -353 -406 Creditors days 14.8 16.7 19.0 18.8 18.4
Others 0 -68 -58 0 0 VALUATION (x)
FINANCING CASH FLOW ( c ) -229 -265 -291 -362 -416 P/E 71.2 69.3 57.2 49.0 42.5
NET CASH FLOW (a+b+c) 140 -64 24 36 118 P/BV 20.9 18.7 15.6 14.3 13.0
EV/EBITDA 52.9 47.2 39.5 34.3 30.0
Price chart EV/Revenues 13.9 12.2 10.4 9.1 8.1
Dividend Yield (%) 0.9 1.0 1.4 1.4 1.6
Dividend Payout (%) 67.3 67.5 77.8 70.0 70.0
(Source: Company, HDFC sec)
11
Crisil Ltd.
Disclosure:
I, Atul Karwa, (MMS-Finance), authors and the names subscribed to this report, hereby certify that all of the views expressed in this research report accurately reflect our views about the subject issuer(s) or securities. HSL has no material adverse disciplinary history as on the date of publication of this report. We also certify that no part of our
compensation was, is, or will be directly or indirectly related to the specific recommendation(s) or view(s) in this report.
Research Analyst or her relative or HDFC Securities Ltd. does not have any financial interest in the subject company. Also Research Analyst or his relative or HDFC Securities Ltd. or its Associate may have beneficial ownership of 1% or more in the subject company at the end of the month immediately preceding the date of publication of the
Research Report. Further Research Analyst or her relative or HDFC Securities Ltd. or its associate does not have any material conflict of interest.
Any holding in stock – No
HDFC Securities Limited (HSL) is a SEBI Registered Research Analyst having registration no. INH000002475.
Disclaimer:
This report has been prepared by HDFC Securities Ltd and is meant for sole use by the recipient and not for circulation. The information and opinions contained herein have been compiled or arrived at, based upon information obtained in good faith from sources believed to be reliable. Such information has not been independently verified and
no guaranty, representation of warranty, express or implied, is made as to its accuracy, completeness or correctness. All such information and opinions are subject to change without notice. This document is for information purposes only. Descriptions of any company or companies or their securities mentioned herein are not intended to be
complete and this document is not, and should not be construed as an offer or solicitation of an offer, to buy or sell any securities or other financial instruments.
This report is not directed to, or intended for display, downloading, printing, reproducing or for distribution to or use by, any person or entity who is a citizen or resident or located in any locality, state, country or other jurisdiction where such distribution, publication, reproduction, availability or use would be contrary to law or regulation or
what would subject HSL or its affiliates to any registration or licensing requirement within such jurisdiction.
If this report is inadvertently sent or has reached any person in such country, especially, United States of America, the same should be ignored and brought to the attention of the sender. This document may not be reproduced, distributed or published in whole or in part, directly or indirectly, for any purposes or in any manner.
Foreign currencies denominated securities, wherever mentioned, are subject to exchange rate fluctuations, which could have an adverse effect on their value or price, or the income derived from them. In addition, investors in securities such as ADRs, the values of which are influenced by foreign currencies effectively assume currency risk.
It should not be considered to be taken as an offer to sell or a solicitation to buy any security. HSL may from time to time solicit from, or perform broking, or other services for, any company mentioned in this mail and/or its attachments.
HSL and its affiliated company(ies), their directors and employees may; (a) from time to time, have a long or short position in, and buy or sell the securities of the company(ies) mentioned herein or (b) be engaged in any other transaction involving such securities and earn brokerage or other compensation or act as a market maker in the
financial instruments of the company(ies) discussed herein or act as an advisor or lender/borrower to such company(ies) or may have any other potential conflict of interests with respect to any recommendation and other related information and opinions.
HSL, its directors, analysts or employees do not take any responsibility, financial or otherwise, of the losses or the damages sustained due to the investments made or any action taken on basis of this report, including but not restricted to, fluctuation in the prices of shares and bonds, changes in the currency rates, diminution in the NAVs,
reduction in the dividend or income, etc.
HSL and other group companies, its directors, associates, employees may have various positions in any of the stocks, securities and financial instruments dealt in the report, or may make sell or purchase or other deals in these securities from time to time or may deal in other securities of the companies / organizations described in this report.
HSL or its associates might have managed or co-managed public offering of securities for the subject company or might have been mandated by the subject company for any other assignment in the past twelve months.
HSL or its associates might have received any compensation from the companies mentioned in the report during the period preceding twelve months from t date of this report for services in respect of managing or co-managing public offerings, corporate finance, investment banking or merchant banking, brokerage services or other advisory
service in a merger or specific transaction in the normal course of business.
HSL or its analysts did not receive any compensation or other benefits from the companies mentioned in the report or third party in connection with preparation of the research report. Accordingly, neither HSL nor Research Analysts have any material conflict of interest at the time of publication of this report. Compensation of our Research
Analysts is not based on any specific merchant banking, investment banking or brokerage service transactions. HSL may have issued other reports that are inconsistent with and reach different conclusion from the information presented in this report.
Research entity has not been engaged in market making activity for the subject company. Research analyst has not served as an officer, director or employee of the subject company. We have not received any compensation/benefits from the subject company or third party in connection with the Research Report.
HDFC securities Limited, I Think Techno Campus, Building - B, "Alpha", Office Floor 8, Near Kanjurmarg Station, Opp. Crompton Greaves, Kanjurmarg (East), Mumbai 400 042 Phone: (022) 3075 3400 Fax: (022) 2496 5066
Compliance Officer: Binkle R. Oza Email: complianceofficer@[Link] Phone: (022) 3045 3600
HDFC Securities Limited, SEBI Reg. No.: NSE, BSE, MSEI, MCX: INZ000186937; AMFI Reg. No. ARN: 13549; PFRDA Reg. No. POP: 11092018; IRDA Corporate Agent License No.: CA0062; SEBI Research Analyst Reg. No.: INH000002475; SEBI Investment Adviser Reg. No.: INA000011538; CIN - U67120MH2000PLC152193
Mutual Funds Investments are subject to market risk. Please read the offer and scheme related documents carefully before investing.
12